| |
COL < 200 (n=184) |
COL≥ 200 (n=164) |
LDL-C < 100 (n=139) |
LDL-C ≥100 (n=172) |
TG < 150 (n=132) |
TG≥ 150 (n=157) |
Gender n (%) Female
Male |
77 (41.8)
107 (58.2) |
75 (45.7)
89 (54.3) |
49 (35.2)
90 (64.8) |
52 (30.2)
120 (69.8) |
54 (40.9)
78 (59.1) |
65 (41.4)
92 (58.6) |
| Ethnicity n (%) Caucasian No Caucasian |
108 (58.7)
76 (41.3) |
100 (61.0)
64 (39.0) |
71 (51.1)
68 (48.9) |
88 (51.2)
84 (48.8) |
78 (59.1)
54 (40.9) |
97 (61.8)
60 (38.2) |
Age (years)
|
40.0
34.0-46.0 |
42.0
36.0-46.0 |
38.0
30.0-45.0 |
40.0
32.0-46.0 |
40.5
34.2-46.8 |
41.0
36.0-45.0 |
BMI (Kg/cm2)
|
23.93
20.96-26.79 |
24.22
21.68-27.29 |
23.1
20.7-26.0 |
23.8
21.5-26.4 |
24.0
21.7-26.9 |
24.7
22.4-27.1 |
WC (cm)
|
89.5
82.5-94.8 |
90.0
86.0-98.0 |
88.0
81.0-97.0 |
89.0
84.0-95.0 |
90.0
84.0-97.0 |
90.0
87.0-98.0 |
HAART n (%) Yes
No |
124 (67.4)
60 (32.6) |
142 (86.6)*
22 (13.4) |
87 (62.6)
52 (37.4) |
128 (74.4)‡
44 (25.6) |
92 (69.7)
40 (30.3) |
127 (80.9)ll
30 (19.1) |
PIs n (%)
Yes
No |
85 (46.2)
99 (53.8) |
92 (56.1)
72 (43.9) |
59 (42.4)
80 (57.6) |
79 (45.9)
93 (54.1) |
51 (38.6)
81 (61.4) |
96 (61.2)¶
61 (38.8) |
NRTIs n (%)
Yes
No |
124 (67.4)
60 (32.6) |
140 (85.4)
†
24 (14.6) |
86 (61.9)
53 (38.1) |
127 (73.8)§
45 (26.2) |
92 (69.7)
40 (30.3) |
126 (80.3)**
31 (19.7) |
NNRTIs n (%) Yes
No |
42 (22.8)
142 (77.2) |
52 (31.7)
112 (68.3) |
27 (19.4)
112 (80.6) |
54 (31.4)*,¶
118 (68.6) |
41 (31.1)
91 (68.9) |
36 (22.9)
121 (77.1) |
|
Chi-square test with Yates’ correction. Mann-Whitney test. Data are expressed median (25%-75%). COL: total cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; BMI: body mass index; WC: waist circumference; IQR: interquartile range (25%-75%); HAART: highly active antiretroviral therapy; PIs: Protease inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NNRTIs: non-nucleoside reverse transcriptase inhibitors
*p<0.0001 (OR: 3.123, CI 95%: 1.811-5.385); †p 0.0002 (OR: 2.823, CI95%: 1.659-4.803); ‡p=0.0339 (OR: 1.739, CI 95%: 1.070-2.825); §p=0.0327 (OR: 1.739, CI 95%: 1.073-2.818); *,¶p=0.0237 (OR: 1.898, CI 95%: 1.118-3.224); llp= 0.0380 (OR: 1.841, CI 95%: 1.068-3.172); ¶p= 0.0002 (OR: 2.500, CI 95%: 1.554-4.020); **p=0.0524 (OR: 1.767, CI 95%: 1.029-3.035) |
| Table 2: Demographic, anthropometric, and clinical characteristics of HIV-1-infected patients from Southern Brazil, according to the serum total cholesterol (TC), lowdensity lipoprotein cholesterol (LDL-C), and triglyceride (TG) levels. |
